Anchen Pharmaceuticals, Inc Report issue

For profit Phase 3
Founded: Irvine CA United States (2004)
Status: Acquired by Par Pharmaceuticals (2011) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
2011
NCT01372423
First Marketed Drug
2006
bupropion (wellbutrin)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ANCHEN PHARMS